Herbs used in cardiovascular diseases

被引:0
作者
Saiyed, Falakaara [1 ]
Maheshwari, Rajesh [1 ]
Gohil, Dilsar [1 ]
Joshi, Krupa [1 ]
机构
[1] Sumandeep Vidyapeeth Deemed Univ, Dept Pharm, Vadodara, Gujarat, India
关键词
Herbs; Medicine; Cardiovascular disease; Potential benefits; Drawbacks; GRAPE SEED EXTRACT; BLOOD-PRESSURE; GINKGO-BILOBA; DIETARY FLAXSEED; ASTRAGALOSIDE IV; ENDOTHELIAL DYSFUNCTION; MOLECULAR-MECHANISMS; GARLIC INTAKE; GREEN TEA; METAANALYSIS;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
One of the many therapeutic uses for herbal medicines is the treatment of cardiovascular diseases. Since medications from traditional systems of medicine do not require official regulatory agency approval or clinical testing before going on the market, they are less frequently proven to be safe and effective than conventional pharmaceuticals. In this review, we summarize the ongoing information on homegrown medicines, essentially utilized in cardiovascular treatment. We show how there is frequently no scientific evidence to support the use of these medications to treat cardiovascular disorders. Despite the fact that they seem to affect organic cycles connected with the cardiovascular framework, there is little data on the restorative impacts of the majority of these herbs. Concerns are raised by the potential for medication contamination or drug substitution with other prescriptions and related negative effects like a higher risk of drug interactions. Doctors should review any potential benefits and drawbacks of their patients' use of herbal remedies in every situation.
引用
收藏
页码:42 / 49
页数:8
相关论文
共 70 条
[61]   Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates [J].
Vitseva, O ;
Varghese, S ;
Chakrabarti, S ;
Folts, JD ;
Freedman, JE .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 46 (04) :445-451
[62]  
Walker AF, 2006, BRIT J GEN PRACT, V56, P437
[63]   Trend and Pattern of Herb and Supplement Use in the United States: Results from the 2002, 2007, and 2012 National Health Interview Surveys [J].
Wu, Chung-Hsuen ;
Wang, Chi-Chuan ;
Tsai, Meng-Ting ;
Huang, Wan-Ting ;
Kennedy, Jae .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
[64]   Ginkgo biloba extract for essential hypertension: A systemic review [J].
Xiong, X. J. ;
Liu, W. ;
Yang, X. C. ;
Feng, B. ;
Zhang, Y. Q. ;
Li, S. J. ;
Li, X. K. ;
Wang, J. .
PHYTOMEDICINE, 2014, 21 (10) :1131-1136
[65]   Astragaloside IV attenuates inflammatory cytokines by inhibiting TLR4/NF-κB signaling pathway in isoproterenol-induced myocardial hypertrophy [J].
Yang, Juan ;
Wang, Hong-Xin ;
Zhang, Ying-Jie ;
Yang, Yu-Hong ;
Lu, Mei-Li ;
Zhang, Jing ;
Li, Sheng-Tao ;
Zhang, Su-Ping ;
Li, Guang .
JOURNAL OF ETHNOPHARMACOLOGY, 2013, 150 (03) :1062-1070
[66]   Effects of Astragalus membranaceus and its main components on the acute phase endothelial dysfunction induced by homocysteine [J].
Zhang, Bi-Qi ;
Hu, Shen-Jiang ;
Qiu, Li-Hong ;
Zhu, Jian-hua ;
Xie, Xian-Ji ;
Sun, Jian ;
Zhu, Zhao-Hui ;
Xia, Qiang ;
Bian, Ka .
VASCULAR PHARMACOLOGY, 2007, 46 (04) :278-285
[67]   Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies [J].
Zhang, Chi ;
Qin, Ying-Yi ;
Wei, Xin ;
Yu, Fei-Fei ;
Zhou, Yu-Hao ;
He, Jia .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (02) :103-113
[68]   Silymarin and its constituents in cardiac preconditioning [J].
Zholobenko, A. ;
Modriansky, M. .
FITOTERAPIA, 2014, 97 :122-132
[69]  
Zhou W, 2004, CARDIOVASC DRUG REV, V22, P309
[70]   Total Flavonoids of Astragalus Plays a Cardioprotective Role in Viral Myocarditis [J].
Zhou, Xiaomin ;
Xin, Qing ;
Wang, Yilin ;
Zhao, Yajun ;
Chai, Hua ;
Huang, Xia ;
Tao, Xiexin ;
Zhao, Ming .
ACTA CARDIOLOGICA SINICA, 2016, 32 (01) :81-88